(Q40534845)

English

Augmenting chemosensitivity of malignant melanoma tumors via proteasome inhibition: implication for bortezomib (VELCADE, PS-341) as a therapeutic agent for malignant melanoma

scientific article published on July 2004

Statements

Augmenting chemosensitivity of malignant melanoma tumors via proteasome inhibition: implication for bortezomib (VELCADE, PS-341) as a therapeutic agent for malignant melanoma (English)
Katayoun I Amiri
Linda W Horton
Bonnie J LaFleur
Jeffrey A Sosman
1 July 2004
4912-4918

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit